Michael Thomas Heffernan insider trades
Open-market stock purchases and sales by Michael Thomas Heffernan, Unknown at Trevi Therapeutics, Inc, from SEC Form 4 filings since May 20, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +29%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc | Sold | $276K |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc | Sold | $316K |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc | Bought (not open market) | $56K |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc | Sold | $1.6K |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc | Bought (not open market) | $70.1K |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc | Bought (not open market) | — |
| Sep 15, 2026 | TRVI Trevi Therapeutics, Inc | Bought (not open market) | — |
| Jun 16, 2026 | ENGN enGene Therapeutics Inc | Bought (not open market) | — |
| Jun 3, 2026 | TRVI Trevi Therapeutics, Inc | Bought (not open market) | — |
| Jun 2, 2026 | AVTX Avalo Therapeutics, Inc | Bought (not open market) | — |
| Apr 28, 2026 | BHVN Biohaven Ltd | Bought (not open market) | — |
Companies traded
- TRVI Trevi Therapeutics, Inc: 1 buy, 3 sales, last Sep 15, 2026
- ENGN enGene Therapeutics Inc: other filings, last Jun 16, 2026
- AVTX Avalo Therapeutics, Inc: other filings, last Jun 2, 2026
- BHVN Biohaven Ltd: other filings, last Apr 28, 2026
- COLL Collegium Pharmaceutical, Inc: 43 sales, last Feb 10, 2025
- SYBX Synlogic, Inc: other filings, last Jun 22, 2023
- AKBA Akebia Therapeutics, Inc: other filings, last Jun 2, 2021
- KERX Keryx Biopharmaceuticals Inc: other filings, last Dec 12, 2018
- OCAT Ocata Therapeutics, Inc: other filings, last Feb 10, 2016
- ACTC Advanced Cell Technology, Inc: other filings, last Sep 30, 2014
- CRTX Cornerstone Therapeutics Inc: other filings, last Feb 3, 2014
Get free alerts when Michael Thomas Heffernan files a new trade →